OpenVSafe by OpenVAERS
Search V-safe

9KP-21509-47242

1 vaccination 7 coded responses 9 check-ins 7 free-text entries 6 call cases
Sex
Female
Age at first dose
36-40
ZIP prefix
521 / IA
Registered
2021-03-18
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-17
    Dose 1 — Janssen/Johnson & Johnson
  2. 2021-03-18
    Registered in v-safe
  3. 2021-03-18
    Survey response — days 1–6 daily, dose 1
    MedDRA: Dizziness, Heart rate increased — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities
    Free text: dizziness, elevated heart rate
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-03-19
    Health check-in — days 1–6 daily, dose 1
    Feeling: Poor · Site: Pain · Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Adult check-in
  5. 2021-04-01
    Survey response — day 14, dose 1
    MedDRA: Abortion spontaneous — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Miscarriage
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-04-01
    Report sent to call center — day 14, dose 1
    Get care from a doctor or other healthcare professional
    1 call case(s)
  7. 2021-04-07
  8. 2021-04-14
    Survey response — day 28, single dose
    MedDRA: Anxiety, Neuropathy peripheral — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit
    Free text: Neuropathy, anxiety
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-04-14
    Report sent to call center — day 28, single dose
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  10. 2021-04-22
    Survey response — day 35, single dose
    MedDRA: Paraesthesia — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit
    Free text: Tingling pins and needles in hands
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-04-22
    Report sent to call center — day 35, single dose
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  12. 2021-04-28
    Health check-in — day 42, single dose
    Feeling: Poor
    Adult check-in
  13. 2021-04-30
  14. 2021-06-16
    Survey response — 3 months, dose 1
    MedDRA: Dizziness, Dyspnoea, Heart rate increased, Hypertension, Neuralgia, Palpitations — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit
    Free text: High heart rate and blood pressure, lightheaded, palpitations, SOB, nerve pain
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-06-16
    Report sent to call center — 3 months, dose 1
    Be unable to work or attend school · Get care from a doctor or other healthcare professional
    1 call case(s)
  16. 2021-06-18
  17. 2021-09-19
    Survey response — 6 months, dose 1
    MedDRA: Bradycardia, Neuropathy peripheral, Paraesthesia — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, Hospitalization
    Free text: Pins Needles neuropathy , bradycardia
    MedDRA releases: 2024-11 · check-in free text available
  18. 2021-09-19
    Report sent to call center — 6 months, dose 1
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  19. 2021-09-20
  20. 2022-03-17
    Survey response — 12 months, dose 1
    MedDRA: Amnesia, Ascites, Bradycardia, Depression, Dizziness, Fatigue, Headache, Hypotension, Insomnia, Menstruation irregular, Palpitations, Paraesthesia, Pleural effusion, Tachycardia — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, Hospitalization
    Free text: Memory loss, tachycardia, bradycardia, headaches, pleural effusion, ascites, low blood pressure, lightheaded, palpitations, insomnia, depression, parasthesia, pins and needles, extreme fatigue, irregular menstural cycle
    MedDRA releases: 2024-11 · check-in free text available
  21. 2022-03-17
    Report sent to call center — 12 months, dose 1
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Emergency room or emergency department visit · Hospitalization · 1 call case(s)
  22. 2022-03-18

Vaccinations

DoseDateManufacturerCo-administered
12021-03-17Janssen/Johnson & Johnson

Call center

ReportedOutcomeVAERS-related outcome
2021-04-01 Unsuccessful
2021-04-14 Unsuccessful
2021-04-22 Unsuccessful
2021-06-16 Unsuccessful
2021-09-19 Unsuccessful
2022-03-17 Unsuccessful

Free text

Release 5 — days 1–6 daily, dose 1

2021-03-18

Systemic reaction (other): dizziness, elevated heart rate

Release 6 — day 14, dose 1

2021-04-01

Symptoms: Miscarriage

Release 7 — day 28, single dose

2021-04-14

Symptoms: Neuropathy, anxiety

Release 7 — day 35, single dose

2021-04-22

Symptoms: Tingling pins and needles in hands

Release 9 — 3 months, dose 1

2021-06-16

Symptoms: High heart rate and blood pressure, lightheaded, palpitations, SOB, nerve pain

Release 9 — 6 months, dose 1

2021-09-19

Symptoms: Pins Needles neuropathy , bradycardia

Release 11 — 12 months, dose 1

2022-03-17

Symptoms: Memory loss, tachycardia, bradycardia, headaches, pleural effusion, ascites, low blood pressure, lightheaded, palpitations, insomnia, depression, parasthesia, pins and needles, extreme fatigue, irregular menstural cycle

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAbortion spontaneous ✓ ✓ ✓
SDAmnesia · · ✓
SDAnxiety ✓ ✓ ✓
SDAscites · · ✓
SDBradycardia · · ✓
SDDepression · · ✓
SDDizziness ✓ ✓ ✓
SDDyspnoea ✓ ✓ ✓
SDFatigue · · ✓
SDHeadache · · ✓
SDHeart rate increased ✓ ✓ ✓
SDHypertension ✓ ✓ ✓
SDHypotension · · ✓
SDInsomnia · · ✓
SDMenstruation irregular · · ✓
SDNeuralgia ✓ ✓ ✓
SDNeuropathy peripheral ✓ ✓ ✓
SDPalpitations ✓ ✓ ✓
SDParaesthesia ✓ ✓ ✓
SDPleural effusion · · ✓
SDTachycardia · · ✓
SRODizziness ✓ ✓ ✓
SROHeart rate increased ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release